Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 344561 - 344580 out of 488720 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (J07BL01) yellow fever, live attenuated | Stamaril 1 000 IE/dose | , sett, Pulver og væske til injeksjonsvæske, suspensjon, 1 000 IE/dose , sett | Retail price with vat |
$0-0 |
$0-0 |
n/a | SanofiWinthropIndustrie |
| Norway | (J07BL01) yellow fever, live attenuated | Stamaril 1 000 IE/dose | , sett, Pulver og væske til injeksjonsvæske, suspensjon, 1 000 IE/dose , sett | Retail price with vat |
$0-0 |
$0-0 |
n/a | SanofiWinthropIndustrie |
| Norway | (J07BL01) yellow fever, live attenuated | Stamaril 1 000 IE/dose | , sett, Pulver og væske til injeksjonsvæske, suspensjon, 1 000 IE/dose , sett | Retail price with vat |
$0-0 |
$0-0 |
n/a | SanofiWinthropIndustrie |
| Norway | (L01EX27) capivasertib | Truqap 160 mg | 64 stk, Blisterpakning, Tablett, filmdrasjert, 160 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaAB |
| Norway | (L01EX27) capivasertib | Truqap 200 mg | 64 stk, Blisterpakning, Tablett, filmdrasjert, 200 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | AstraZenecaAB |
| Norway | (L01FC02) isatuximab | Sarclisa 20 mg/ml | 5 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie |
| Norway | (L01FC02) isatuximab | Sarclisa 20 mg/ml | 25 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie |
| Norway | (L01FX05) brentuximab vedotin | Adcetris 50 mg | 50 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 50 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Hodgkin Disease | TakedaPharmaA/S(1) |
| Norway | (L01FX20) tremelimumab | Imjudo 20 mg/ml | 1 x 1.25 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | AstraZenecaAB |
| Norway | (L01FX20) tremelimumab | Imjudo 20 mg/ml | 1 x 15 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Non-Small-Cell Lung | AstraZenecaAB |
| Norway | (L01FX26) mirvetuximab soravtansine | Elahere 5 mg/ml | 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 5 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms | AbbVieDeutschlandGmbH&Co |
| Norway | (L01XA02) carboplatin | Carboplatin Accord 10 mg/ml | 45 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 10 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01XA02) carboplatin | Carboplatin Accord 10 mg/ml | 60 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 10 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01XA02) carboplatin | Carboplatin Accord 10 mg/ml | 5 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 10 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01XA02) carboplatin | Carboplatin Accord 10 mg/ml | 15 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 10 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L02BX03) abiraterone (adm: O) | Zytiga 500 mg | 56 stk, Blisterpakning, Tablett, filmdrasjert, 500 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | OrifarmAS |
| Norway | (L04AE03) siponimod | Mayzent 0,25 mg | 12 stk, Blisterpakning, Tablett, filmdrasjert, 0,25 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisEuropharmLimited(1) |
| Norway | (L04AE03) siponimod | Mayzent 0,25 mg | 120 stk, Blisterpakning, Tablett, filmdrasjert, 0,25 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisEuropharmLimited(1) |
| Norway | (L04AE03) siponimod | Mayzent 2 mg | 28 stk, Blisterpakning, Tablett, filmdrasjert, 2 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NovartisEuropharmLimited(1) |
| Norway | (L04AG08) ocrelizumab (adm: P) | Ocrevus 300 mg | 1 x 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 300 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Multiple Sclerosis | RocheRegistrationGmbH |
Pages
